Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Styl ...

Donaldson Company (DCI) FY Conference June 05, 2025 11:40 AM ET Speaker0 Okay. We'll go ahead and get started. Thank you all for coming to the Donaldson presentation. I'm Brian Draub, the Industrial Technology Analyst at William Blair. I've covered Donaldson for seventeen years now. So today we're happy to have with us CEO, Todd Carpenter CFO, Brad Pogals. It's not Pogals. Pogals. Pogals. Pogals. Okay. Speaker1 Got it. Speaker0 See every detail and I blew one of them. And Sarka Dodwal, who is the Senior Dir ...

Key Takeaways DCI's Q3 EPS of $0.99 beat estimates and rose 7.6%, while revenues rose 1.3% to $940.1 million. Donaldson saw 5.3% growth in Industrial Solutions, while Mobile sales dropped 0.4% year over year. DCI ups FY25 EPS forecast to $3.64-$3.70, with 1-3% sales growth and strong Life Sciences outlook.Donaldson Company, Inc. (DCI) reported third-quarter fiscal 2025 (ended April 30, 2025) adjusted earnings of 99 cents per share, which beat the Zacks Consensus Estimate of 95 cents. The bottom line incre ...

Donaldson Company, Inc. (NYSE:DCI) Q3 2025 Earnings Conference Call June 3, 2025 10:00 AM ET Company Participants Sarika Dhadwal - Senior Director of IR & ESG Tod Carpenter - Chairman, President and CEO Brad Pogalz - CFO Conference Call Participants Angel Castillo - Morgan Stanley Bryan Blair - Oppenheimer Dan Rizzo - Jefferies Rob Mason - Baird Tim Thein - Raymond James Adam Farley - Stifel Operator Good morning and welcome to Donaldson's Third Quarter Fiscal 2025 Earnings Conference Call and Webcast. All ...

Financial Performance - Net sales for the three months ended April 30, 2025, were $940.1 million, a 1.3% increase from $927.9 million in the same period of 2024[106]. - Net sales for the nine months ended April 30, 2025, were $2,710.2 million, an increase of $59.3 million, or 2.2%, compared to $2,650.9 million for the same period in 2024[122]. - Net earnings for the three months ended April 30, 2025, were $57.8 million, a decrease of $55.7 million, or 49.1%, from $113.5 million in the same period of 2024[117]. - Net earnings for the nine months ended April 30, 2025, were $252.7 million, a decrease of $51.6 million, or 16.9%, compared to $304.3 million in 2024[130]. - Diluted earnings per share (EPS) decreased to $0.48 for the three months ended April 30, 2025, down from $0.92 in the prior year, a decline of 48.0%[117]. Segment Performance - The Industrial Solutions segment saw a sales increase of $14.2 million, or 5.3% growth, while the Mobile Solutions segment experienced a decline of $2.6 million, or 0.4%[108]. - The Mobile Solutions segment reported net sales of $1,702.6 million for the nine months ended April 30, 2025, an increase of $27.1 million, or 1.6%, compared to $1,675.5 million in 2024[140]. - Net sales for the Industrial Solutions segment for the three months ended April 30, 2025, were $283.3 million, an increase of $14.2 million, or 5.3%, compared to $269.1 million for the same period in 2024[146]. - Aerospace and Defense net sales increased by $11.0 million due to ongoing strength in the end markets, while Industrial Filtration Solutions (IFS) net sales increased by $3.2 million driven by replacement part sales[147]. - Net sales for the Life Sciences segment for the three months ended April 30, 2025, were $74.2 million, an increase of $0.6 million, or 0.7%, compared to $73.6 million for the same period in 2024[160]. Expenses and Costs - Gross margin as a percentage of net sales decreased to 34.2% for the three months ended April 30, 2025, down from 35.6% in the prior year, primarily due to higher manufacturing costs[109]. - Selling, general and administrative expenses decreased by $10.6 million, or 6.5%, to $151.1 million, representing 16.1% of net sales[110]. - Research and development expenses decreased by $3.4 million, or 14.0%, to $21.4 million, representing 2.3% of net sales[112]. - Selling, general and administrative expenses were $476.4 million, or 17.6% of net sales, for the nine months ended April 30, 2025, compared to $473.5 million, or 17.9% in 2024[124]. - Research and development expenses decreased by $2.9 million, or 4.4%, to $65.3 million, representing 2.4% of net sales for the nine months ended April 30, 2025[126]. Impairment and Tax - The company reported a loss on impairment of intangible assets of $62.0 million, or 6.6% of net sales, compared to no expense in the same period of 2024[111]. - Loss on impairment of intangible assets was $62.0 million, or 2.3% of net sales, for the nine months ended April 30, 2025, compared to no expense in 2024[125]. - The effective tax rate increased to 33.6% for the three months ended April 30, 2025, compared to 21.2% in the same period of 2024, primarily due to the impairment loss[115]. - The effective tax rate increased to 26.2% for the nine months ended April 30, 2025, compared to 23.1% in 2024, primarily due to the impairment loss[129]. Cash Flow and Debt - Cash provided by operating activities for the nine months ended April 30, 2025, was $251.0 million, a decrease of $115.5 million compared to $366.5 million for the same period in 2024[170]. - Cash used in investing activities for the nine months ended April 30, 2025, was $129.8 million, an increase of $62.0 million compared to $67.8 million for the same period in 2024[171]. - Total debt as of April 30, 2025, was $638.8 million, an increase of $130.4 million from $508.4 million as of July 31, 2024[177]. - Cash and cash equivalents as of April 30, 2025, were $178.5 million, down from $232.7 million as of July 31, 2024[174]. - Dividends paid for the nine months ended April 30, 2025, were $96.9 million, compared to $90.3 million for the same period in 2024[173]. Foreign Currency and Interest Rates - The estimated impact of foreign currency translation for the nine months ended April 30, 2025, resulted in a decrease in reported net sales of $10.1 million and a decrease in reported net earnings of $3.4 million[187]. - The overall stronger U.S. dollar negatively impacted the Company's international net sales and net earnings due to foreign-denominated revenues translating into less U.S. dollars[187]. - As of April 30, 2025, the total notional amount of foreign currency forward contracts designated as hedges was $32.4 million, while those not designated as hedges amounted to $194.3 million[189]. - The total notional amount of net investment hedges as of April 30, 2025, was €80 million, or $88.8 million, with maturity dates ranging from 2027 to 2029[190]. - Assuming a hypothetical 0.5 percentage point increase in short-term interest rates, interest expense would have increased approximately $1.7 million in the nine months ended April 30, 2025[192].

Donaldson Company (DCI) Q3 2025 Earnings Call June 03, 2025 10:00 AM ET Company Participants Sarika Dhadwal - Sr. Director - IR & ESGTod Carpenter - Chairman, CEO & PresidentBrad Pogalz - Chief Financial OfficerAngel Castillo - Executive DirectorTyler Mulier - Equity Research Associate Conference Call Participants Bryan Blair - Managing Director & Senior Research AnalystDaniel Rizzo - AnalystRobert Mason - Senior Research AnalystTim Thein - Managing Director & Research AnalystAdam Farley - Associate Analyst ...

Financial Data and Key Metrics Changes - For the third quarter of fiscal 2025, consolidated sales rose 1% year over year to $940 million, with modest volume growth offset by currency translation headwinds [9][20] - Adjusted EPS was $0.99, up approximately 8% compared to the prior year [10][21] - Operating margin improved by 80 basis points over the previous year, driven by expense leverage [9][21] Business Line Data and Key Metrics Changes - In Mobile Solutions, total sales were $583 million, roughly flat with the prior year, with aftermarket sales increasing by 3% to $460 million [13][14] - Industrial Solutions sales rose 5% to $283 million, with IFS sales at $232 million, a 1% increase from the prior year [15][16] - Life Sciences sales grew 1% to $74 million, with double-digit growth in disk drive and food and beverage replacement parts [16][17] Market Data and Key Metrics Changes - Mobile Solutions in China saw a 27% increase in sales, driven by growth in both first fit and aftermarket [15] - Aerospace and defense sales reached a record $52 million, largely due to robust market demand [7][16] - The impact of tariffs on net results was deemed immaterial for the quarter, with an annualized estimate of $35 million expected to be offset through supply chain and price adjustments [10][12] Company Strategy and Development Direction - The company is focused on long-term investments in technology opportunities and capital expenditures while maintaining a strong balance sheet [5][30] - A new COO was appointed to strengthen execution across the organization [6] - The company aims to navigate dynamic market conditions while advancing innovation and growth initiatives [35] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver long-term value despite macro uncertainties [4][35] - The company anticipates fiscal 2025 to be another record year, with record sales, operating margin, and adjusted earnings [17][34] - Management acknowledged ongoing market headwinds in bioprocessing but remains committed to strategic investments [23][24] Other Important Information - The company announced an 11% increase in its quarterly dividend, marking the 30th consecutive year of annual dividend increases [32][33] - Share repurchases totaled 2.4% of outstanding shares for $192 million during the quarter, with expectations to increase the full-year repurchase to between 3-4% [33] Q&A Session Summary Question: Can you discuss the gross profit margin dynamics and inflation impacts? - The decline in gross margin was primarily due to footprint optimization initiatives, with expectations to remain price-cost neutral [37][39][41] Question: What is driving the lowered CapEx outlook? - The company is prioritizing executing business operations over launching new CapEx projects due to supply chain pressures [42][44] Question: Can you provide insights on Industrial Solutions top-line trends? - The equipment side is pressured, but aftermarket growth and share gains in stationary hydraulics are offsetting challenges [49][51] Question: What is the visibility in aerospace and defense? - The company has long visibility on projects, but supply chain uncertainties make predictions challenging [62][68] Question: How does the company view the impact of tariffs on demand? - The company is managing carefully amidst uncertainties, with aftermarket and service-based businesses performing well [100][101]

For the quarter ended April 2025, Donaldson (DCI) reported revenue of $940.1 million, up 1.3% over the same period last year. EPS came in at $0.99, compared to $0.92 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $938.8 million, representing a surprise of +0.14%. The company delivered an EPS surprise of +4.21%, with the consensus EPS estimate being $0.95.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...

Donaldson (DCI) came out with quarterly earnings of $0.99 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.92 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.21%. A quarter ago, it was expected that this maker of filtration systems would post earnings of $0.85 per share when it actually produced earnings of $0.83, delivering a surprise of -2.35%.Over the last four quarters, ...

D O N AL D S O N C O M P AN Y THIRD QUARTER FISCAL YEAR 2025 J UN E 2 02 5 Forward-Looking Statement Safe Harbor Statements in this presentation regarding future events and expectations, such as forecasts, plans, trends, and projections relating to the Company's business and financial performance, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are identified by words or phrases such as "will likely result," "are expected to," "will continue," "w ...